NEW! Quotes from the London Stock Exchange and Enhanced Symbol Lookup
» Learn more
» Learn more
- Thursday, 2 Jul 2009 4:21 PM ETBy: Mike Huckman
Since we're headed into a long summer holiday weekend, I'm gonna keep things light. Besides, at the moment, I'm on cloud nine. » Read more - Wednesday, 1 Jul 2009 3:25 PM ETBy: Mike Huckman
Today the Food and Drug Administration announced that Pfizer's Chantix and GlaxoSmithKline's Zyban will carry new warnings about mental side effects. Not just any old warnings, but so-called "Black Box" warnings. Or, at least, that's what we in the news media used to call them. Until the FDA called us out today. » Read more - Monday, 29 Jun 2009 11:23 AM ETBy: Mike Huckman
Shares of Sanofi-Aventis are getting a little investor injection on the back of the emergency release of the Lantus diabetic insulin studies late last Friday. » Read more - Friday, 26 Jun 2009 1:18 PM ETBy: Mike Huckman
Shares of the French drugmaker are getting pummeled over at least three analyst reports identifying a leak about a study or studies that could go public soon. Their research suggests the data is related to a suspected or "theoretical" higher cancer risk associated with SNY's Lantus. » Read more - Thursday, 25 Jun 2009 1:27 PM ETBy: Mike Huckman
Man, it's gotta hurt when the publicly-traded company you've been leading for years announces you're stepping down and investors pop the champagne corks. » Read more - Wednesday, 24 Jun 2009 12:56 PM ETBy: Mike Huckman
ACC, ADA, AHA, ASCO, ICAD, TCT. That's just a handful of the acronyms and abbreviations for scientific and medical conferences that I've attended over the years. But this year I might be able to add RITA to my dance card. I'd never heard of her (it) before this morning when I got this press release from Crucell, which owns technology for faster, better, cheaper vaccine manufacturing. » Read more - Monday, 22 Jun 2009 12:46 PM ETBy: Mike Huckman
The growing, influential role of Twitter has never been more evident than during the recent Iranian uprising. But did the story that "The Wall Street Journal" broke last Friday night about Apple's Steve Jobs getting a liver transplant actually appear on Twitter first? » Read more - Thursday, 18 Jun 2009 12:34 PM ETBy: Mike HuckmanTwo days after the FDA ordered Matrixx Initiatives' Zicam off the market the story remains one of the most emailed articles on "The New York Times" website. And the company seems to still be trying to find its corporate crisis footing. » Read more
ABOUT PHARMA'S MARKET
Pharma's Market is more than just a play on words. Think of this blog written by Mike Huckman as a “farmer's market”—a place where you'll find a wide assortment of fresh stuff related to the drug, biotech and medical device industries. Mike will try to harvest topics from fertile, untilled ground. And yes, occasionally, he'll go off the farm.
BIO
Mike Huckman is the author of CNBC.com’s Pharma’s Market and CNBC's Pharmaceuticals Reporter covering the drug, biotechnology and medical device industries. Huckman joined the network in 2000 and is based at the network’s global headquarters in Englewood Cliffs, N.J. Read full bio here.
- Your First Move For Monday July 6th
- Web Extra: Hot Options Action w/ Pete Najarian
- This Day In Fast Money History – July 2nd
- Trade In America: Ford
- Pops & Drops: Evergreen Solar, TiVo...
- Stock of the Day: Sanderson Farms
- Don’t Bet On USA
- Why Is Morgan Stanley Bullish Airlines?
- Can Stocks Withstand Stormy Earnings Season?
- Cramer: How to Call a Bottom
MIKE HUCKMAN'S FAVORITE LINKS
RSS FEED
» Help
About CNBC | Site Map | Privacy Policy | Terms of Service | Video Reprints | Advertise | Help | Contact
Partners: AOL Money | BloggingStocks.com
CNBC is a Division of NBC Universal
Partners: AOL Money | BloggingStocks.com
CNBC is a Division of NBC Universal
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2009 CNBC, Inc. All Rights Reserved.
